Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes DOI Creative Commons
Carmen Hierro‐Bujalance, Mónica Garcı́a-Alloza

Neural Regeneration Research, Journal Year: 2023, Volume and Issue: 19(6), P. 1189 - 1190

Published: Sept. 22, 2023

Division of Physiology, School Medicine, Universidad de Cadiz, Spain (Hierro-Bujalance C, Garcia-Alloza M) Instituto Investigacion e Innovacion en Ciencias Biomedicas la Provincia Cadiz (INIBICA), Salus Infirmorum-Universidad C) *Correspondence to: Monica Garcia-Alloza, PhD, [email protected]. This is an open-access article distributed under the terms Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided original work properly cited.

Language: Английский

Dietary factors and Alzheimer’s disease risk: a Mendelian randomization study DOI Creative Commons
Qi Meng,

Chen Chen,

Mingfang Zhu

et al.

European journal of medical research, Journal Year: 2024, Volume and Issue: 29(1)

Published: May 2, 2024

Language: Английский

Citations

3

Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement DOI Open Access
Cristina Popescu, Constantin Munteanu, Aurelian Anghelescu

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(20), P. 11272 - 11272

Published: Oct. 19, 2024

Recent studies underscore the role of gut and oral microbiota in influencing neuroinflammation through microbiota–gut–brain axis, including Alzheimer’s disease (AD). This review aims to provide a comprehensive synthesis recent findings on involvement neuroinflammatory processes associated with AD, emphasizing novel insights therapeutic implications. reveals that dysbiosis AD patients’ is linked heightened peripheral central inflammatory responses. Specific bacterial taxa, such as Bacteroides Firmicutes gut, well Porphyromonas gingivalis cavity, are notably altered leading significant changes microglial activation cytokine production. Gut alterations increased intestinal permeability, facilitating translocation endotoxins like lipopolysaccharides (LPS) into bloodstream exacerbating by activating brain’s toll-like receptor 4 (TLR4) pathways. Furthermore, microbiota-derived metabolites, short-chain fatty acids (SCFAs) amyloid peptides, can cross blood-brain barrier modulate While microbial amyloids may contribute amyloid-beta aggregation brain, certain SCFAs butyrate exhibit anti-inflammatory properties, suggesting potential avenue mitigate neuroinflammation. not only highlights critical pathology but also offers ray hope modulating could represent strategy for reducing slowing progression.

Language: Английский

Citations

3

The Relationship between Diet, Depression, and Alzheimer's Disease: A Narrative Review DOI Creative Commons

Hilal Salim Said Al Shamsi,

Stephanie R. Rainey‐Smith, Samantha L. Gardener

et al.

Molecular Nutrition & Food Research, Journal Year: 2024, Volume and Issue: 68(13)

Published: July 1, 2024

Purpose of Review This narrative review evaluates the role diet in relationship between depression and Alzheimer's disease (AD). Recent Findings AD are often comorbid, appears to independently increase future risk AD. Evidence suggests influences both conditions directly indirectly. Diet impacts neurochemical biological processes that may affect development progression cognitive dysfunction. The dietary components offering greatest protection against yet be determined. Current evidence highlights importance polyphenolic compounds, folate, B vitamins, polyunsaturated fatty acids, along with adherence patterns like Mediterranean diet, which includes multiple beneficial factors. Summary investigation factors prevention is a comparatively young field research. Comprehensive highly characterised longitudinal datasets advanced analytical approaches required further examine complex depression, There critical need for more research this area develop effective preventive strategies aimed at maintaining mental physical health advancing age.

Language: Английский

Citations

2

Topical Cellular/Tissue and Molecular Aspects Regarding Nonpharmacological Interventions in Alzheimer’s Disease—A Systematic Review DOI Open Access
Sorina Maria Aurelian, Adela Magdalena Ciobanu, Roxana O. Carare

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(22), P. 16533 - 16533

Published: Nov. 20, 2023

One of the most complex and challenging developments at beginning third millennium is alarming increase in demographic aging, mainly—but not exclusively—affecting developed countries. This reality results one harsh medical, social, economic consequences: continuously increasing number people with dementia, including Alzheimer’s disease (AD), which accounts for up to 80% all such types pathology. Its large progressive disabling potential, eventually leads death, therefore represents an important public health matter, especially because there no known cure this disease. Consequently, periodic reappraisals different therapeutic possibilities are necessary. For purpose, we conducted systematic literature review investigating nonpharmacological interventions AD, their currently cellular molecular action bases. endeavor was based on PRISMA method, by selected 116 eligible articles published during last year. Because unfortunate lack effective treatments it necessary enhance efforts toward identifying improving various rehabilitative approaches, as well related prophylactic measures.

Language: Английский

Citations

6

Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes DOI Creative Commons
Carmen Hierro‐Bujalance, Mónica Garcı́a-Alloza

Neural Regeneration Research, Journal Year: 2023, Volume and Issue: 19(6), P. 1189 - 1190

Published: Sept. 22, 2023

Division of Physiology, School Medicine, Universidad de Cadiz, Spain (Hierro-Bujalance C, Garcia-Alloza M) Instituto Investigacion e Innovacion en Ciencias Biomedicas la Provincia Cadiz (INIBICA), Salus Infirmorum-Universidad C) *Correspondence to: Monica Garcia-Alloza, PhD, [email protected]. This is an open-access article distributed under the terms Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided original work properly cited.

Language: Английский

Citations

4